An in-depth study of the complex regulation of Tie2 should increase our understanding of the molecular mechanisms of the progression of CLD, providing novel and valuable therapeutic strategies for antifibrotic pharmacological interventions. The gene discussed is TEK; the disease is congenital secretory chloride diarrhea 1.